The stockmarket’s Santa rally has been cancelled
With chaos spreading through supply chains and talk of domestic virus restrictions remaining in place until Easter, markets have not been feeling festive.

“’Twas the nightmare before Christmas,” says Stephen Innes of Axi. The appearance of a new and potentially more transmissible strain of Covid-19 in southern England has squashed hopes of a traditional pre-Christmas “Santa rally”. With chaos spreading through supply chains and talk of domestic virus restrictions remaining in place until Easter, markets have not been feeling festive. The FTSE 100 fell by 2.9% on Monday before paring losses, with the FTSE 250 finishing the day down more than 2%. The price of oil dropped 4% and the pound had its worst day since September.
Recovery delayed, not denied
If the early reports about the new virus strain are accurate then “extended and severe lockdowns for the majority” of the first quarter of 2021 now look a real possibility, says Innes. That is undermining optimism about a swift economic rebound in the new year.
The UK is heading for a double-dip recession, says Dan Hanson of Bloomberg Economics. GDP was already set to contract this quarter because of the lockdown and now looks set to fall during the first three months of 2021 too. There was better news this week from America, where congressional leaders agreed on a $900bn pandemic relief package.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
For the global economy, the key story for next year remains a recovery on the back of mass vaccination, says Jeremy Warner in The Daily Telegraph. Ongoing fiscal and monetary support are laying the groundwork for a roaring 2021. Between April and June nearly “one in every three pounds earned” in the UK was being saved, with Britons now sitting on an estimated £200bn savings pile. When the pandemic is over “collectively we will want to treat ourselves”.
Buy Britain
The FTSE 100 has continued to underperform peers this year, falling 15.5% so far in 2020. That compared with a 9% fall on the Euro Stoxx 50 and a 13% rise of the S&P 500. Yet a long period of disappointment gives the FTSE room to rise, says Chris St John of AXA Investment Managers. “Deal or no-deal, we expect the FTSE 100 to go up”. A Brexit deal would give investors the confidence they need to buy into Britain again. On the other hand, no-deal would knock sterling lower, which will make FTSE 100 earnings – 70% of which come from overseas – appear stronger in pound terms. That said, the effect of a disruptive no-deal on mid- and small-cap shares would be “indiscriminately” negative.
Still, as MoneyWeek has pointed out for much of the year, near-term disruption looks to be in the price. On a cyclically adjusted price/earnings ratio (Cape) of 11.8 as of the end of October, the UK market trades at a huge discount to the developed market average of 23.4.
But tread carefully in America. The S&P 500’s Cape ratio reached 33.1 last month – higher than the 32.6 it hit in the run-up to the Wall Street crash of 1929. There is a lot of potential downside for US equities.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Lloyds axes foreign currency fees for Club Lloyds customers
Club Lloyds customers will be able to withdraw their money abroad without incurring any extra fees
By Daniel Hilton Published
-
How to invest during stagflation
Trump’s tariffs look poised to push the global economy into a period of stagflation. We look at how to ensure your investments can survive a global slowdown.
By Dan McEvoy Published
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge Published
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge Published
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field Published
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs Published
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward Published
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves Published
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine Published
-
Pensions revolution: how to profit from the trends shaping the UK pension system
The UK pension system is one of the biggest in the world. Big changes are under way, says Rupert Hargreaves
By Rupert Hargreaves Published